KevinJBlinderMD

Ophthalmology • Brentwood, MO

Retinal Disease

Partner, The Retina Institute Professor of Clinical Ophthalmology Washington University

Join to view full profile

Dr. Blinder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Blinder's full profile

Already have an account?

Office
1600 S Brentwood Blvd Ste 700
Brentwood, MO 63144
Phone+1 314-367-1181

Fax+1 314-968-5117

Education & Training

Louisiana State University School of Medicine (New Orleans)Residency, Ophthalmology, 1989 - 1991
University of Missouri-ColumbiaResidency, Ophthalmology, 1986 - 1989
SSM St Mary's Hospital-St LouisInternship, Internal Medicine, 1985 - 1986
University of Missouri Kansas City School of MedicineClass of 1985

Certifications & Licensure

IL State Medical License 1999 - 2026
MO State Medical License 1986 - 2025
LA State Medical License 1989 - 2001
AL State Medical License 1998 - 1999
KY State Medical License 1995 - 1999
TN State Medical License 1995 - 1999
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis Start of enrollment: 2007 Oct 01
Unknown status
Phase 2
Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations Start of enrollment: 2009 Apr 01
Completed
Phase 2
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane Start of enrollment: 2011 Aug 01
Terminated
Not Applicable
Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome Start of enrollment: 2012 Jun 01
Completed
Phase 1
The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy Start of enrollment: 2019 Nov 15
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

72 citations
Primary Retinal Detachment Outcomes Study Report Number 2: Phakic Retinal Detachment Outcomes
Edwin H. Ryan, Claire Ryan, Nora J. Forbes, Yoshihiro Yonekawa, Sushant Wagley
Ophthalmology. 2020-03-09
90 citations
Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1).
Kevin J. Blinder, Pravin U. Dugel, Sanford Chen, J. Michael Jumper, John G. Walt
Clinical Ophthalmology. 2017-02-21
84 citations
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials.
Gui-Shuang Ying, Benjamin J. Kim, Maureen G. Maguire, Jiayan Huang, Ebenezer Daniel
JAMA Ophthalmology. 2014-08-01

Press Mentions

What Are Beovu Side Effects?December 20th, 2021
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Advances for Uveal Melanoma, Vitrectomies, Intravitreal Injections and Other Highlights from ASRS 2018August 10th, 2018
Join now to see all

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow